Safety Evaluation of Recombinant Fusion Protein RP22 as a Skin Test Reagent for Tuberculosis Diagnosis: A Phase I Clinical Trial

por Xia, Lu, Liu, Xu-hui, Zhao, Zhang-yan, Li, Tao, Xi, Xiu-hong, Liu, Ping, Huang, Wei, Fan, Xiao-yong, Wu, Xue-qiong, Lu, Shui-hua
Publicado 2021